MC Trio股票缓冲主动型ETF TRIO 深 沪
等待开盘 08-21 09:30:00 美东时间
65.72
-0.227
-0.34%
华盛通- 最 高65.7549
- 今 开65.72
- 成交量 3546股
- 最 低 65.72
- 昨 收 65.9466
- 总市值 1.23亿
- 52周最高 66.2717
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 58.5665
- 委 比 0.00%
- 总股本 187.00万
- 历史最高 66.2717
- 量 比 0
- 振 幅 0.05%
- 历史最低 48.6048
- 每 手 1
- 风险率 2.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多KBR wins $60M contract to support NATO missile defense
KBR (KBR) said on Monday that its Mission Technology Solutions business has won a NATO recompete contract with an initial ceiling of $60M to support the PATRIOT air and missile defense system and its ...
08-17 18:18
Golden Dome missile shield could top $1.2T, budget watchdog says
A new estimate from the Congressional Budget Office suggests that the cost of building and maintaining the proposed “Golden Dome” missile defense system could reach roughly $1.2 trillion over two deca...
05-13 20:12
Israel approves major fighter jet expansion with new F-35 and F-15 squadrons
Israel on Sunday approved plans to acquire two additional combat squadrons of advanced fighter aircraft from Lockheed Martin (LMT) and Boeing (BA), part of a broader military buildup aimed at preservi...
05-03 22:07
U.S. approves $8.6B military sales to Middle Eastern allies
The Trump administration has approved military sales worth more than $8.6B to America’s Middle Eastern allies, Israel, Qatar, Kuwait, and the UAE, benefiting weapons manufacturers such as Northrop Gru...
05-02 22:32
The FDA Approves Premarket Approval Application For NEXUS Aortic Arch System, Developed By Artivion's Partner; The Approval Entitles Artivion To Exercise Its Option To Acquire Endospan At Any Time Within 90 Days
Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA)
04-07 19:08
